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Background: Burkholderia (B.) pseudomallei and B. mallei are genetically closely related species. B. pseudomallei
causes melioidosis in humans and animals, whereas B. mallei is the causative agent of glanders in equines and
rarely also in humans. Both agents have been classified by the CDC as priority category B biological agents. Rapid
identification is crucial, because both agents are intrinsically resistant to many antibiotics. Matrix-assisted laser
desorption/ionisation mass spectrometry (MALDI-TOF MS) has the potential of rapid and reliable identification of
pathogens, but is limited by the availability of a database containing validated reference spectra. The aim of this
study was to evaluate the use of MALDI-TOF MS for the rapid and reliable identification and differentiation of B.
pseudomallei and B. mallei and to build up a reliable reference database for both organisms.
Results: A collection of ten B. pseudomallei and seventeen B. mallei strains was used to generate a library of
reference spectra. Samples of both species could be identified by MALDI-TOF MS, if a dedicated subset of the
reference spectra library was used. In comparison with samples representing B. mallei, higher genetic diversity
among B. pseudomallei was reflected in the higher average Eucledian distances between the mass spectra and a
broader range of identification score values obtained with commercial software for the identification of
microorganisms. The type strain of B. pseudomallei (ATCC 23343) was isolated decades ago and is outstanding in
the spectrum-based dendrograms probably due to massive methylations as indicated by two intensive series of
mass increments of 14 Da specifically and reproducibly found in the spectra of this strain.
Conclusions: Handling of pathogens under BSL 3 conditions is dangerous and cumbersome but can be minimized
by inactivation of bacteria with ethanol, subsequent protein extraction under BSL 1 conditions and MALDI-TOF MS
analysis being faster than nucleic amplification methods. Our spectra demonstrated a higher homogeneity in B.
mallei than in B. pseudomallei isolates. As expected for closely related species, the identification process with MALDI
Biotyper software (Bruker Daltonik GmbH, Bremen, Germany) requires the careful selection of spectra from reference
strains. When a dedicated reference set is used and spectra of high quality are acquired, it is possible to distinguish
both species unambiguously. The need for a careful curation of reference spectra databases is stressed.* Correspondence: herbert.tomaso@fli.bund.de
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Burkholderia (B.) pseudomallei and B. mallei are genet-
ically closely related bacterial species that can cause fatal
disease in humans and animals. B. pseudomallei is a fac-
ultative intracellular soil bacterium and the cause of
melioidosis, which has the highest prevalence in the hot
and humid regions of Southeast Asia, and Northern
Australia. The infection can be acquired by contact with
contaminated soil or water by inhalation or percutan-
eously. Human infections can be asymptomatic, can
present with focal lesions that may affect almost any
organ, or may be disseminate resulting in pneumonia
and septicaemia. In certain regions of Asia melioidosis is
a major cause of human morbidity and acute systemic
melioidosis has a case fatality rate of up to 50% even if
treated [1,2]. Melioidosis has been described in wild ani-
mals, but also in farm and pet animals and can be spread
by animal trade and transport [3]. Both species are
pathovars of a single genomospecies which was divided
historically in two separate species due to their clinical
impact and host tropism. B. thailandensis is the third
closely related species of the so-called “Pseudomallei
complex” which has been out-grouped from the species
B. pseudomallei based on arabinose fermentation and its
markedly lower pathogenicity. B. thailandensis and B.
pseudomallei are soil bacteria that share the same geo-
graphical distribution.
B. mallei is a gram-negative, non-motile obligate
pathogen and the causative agent of glanders and farcy
in equines (horses, donkeys, mules). In horses, glanders
primarily presents with purulent nasal discharge, inflam-
mation of the mucous membranes of the upper respira-
tory tract, and poor general condition, whereas farcy is a
chronic cutaneous disease with formation of nodules
which may develop into ulcers. Equines are the only
known reservoir. Contact with infected animals, inges-
tion of glanderous meat and exposure to aerosols can
cause B. mallei infections in humans. Human glanders is
highly lethal and resembles melioidosis. Chronic and la-
tent infections can exacerbate into the acute form even
after 15 years in both diseases. Both bacterial species are
intrinsically resistant to many antibiotics including ampi-
cillin and broad- and expanded-spectrum cephalospor-
ines due to the production of a beta-lactamase [4]. B.
mallei and B. pseudomallei have been classified by the
CDC as priority category B biological agents.
Isolation and microbiological identification of B. pseu-
domallei and B. mallei from clinical samples can take up
to one week. Commercial biochemical test systems for
B. mallei are not available and B. pseudomallei may be
misidentified as Chromobacterium violaceum or other
bacteria [5-7]. Latex agglutination using a monoclonal
antibody was shown to be a valuable technique for the
rapid identification of B. pseudomallei in positive bloodcultures, but no commercial tests are available [8,9].
Real-time PCR systems have been developed for diag-
nosing and differentiating as rapid alternatives to bio-
chemical tests, but few have been validated on clinical
samples [10-13].
Matrix-assisted laser desorption ionization-time of
flight mass spectrometry (MALDI-TOF MS) for identifi-
cation of bacteria has become a useful tool for the rapid
identification of bacteria (see [14] for a recent review).
In some studies intact cell mass spectrometry (ICMS)
showed better correlation to genetic markers than con-
ventional morphological classification [15]. The tech-
nique and modified procedures including a digestion
step (‘shotgun mass mapping’) have been successfully
used for subspecies-level classification in some species
[16]. Characteristic features of ICMS are simple sample
preparation procedures of whole cells, spectrum acquisi-
tion in the mass range between approximately 2,000 and
15,000 Da and analysis based upon comparison of sam-
ple spectra with reference spectra. By statistical
approaches, similarity between mass spectra can be
exploited for the identification of microorganisms.
MALDI-TOF MS was also established for identification
of non-fermenting gram-negative bacteria isolated from
cystic fibrosis patients in Brazil [17]. Patients with cystic
fibrosis suffer primarily under infections with Pseudo-
monads, but Burkholderiae play also an important role.
In the Brazilian study a comprehensive number of Bur-
kholderia species was included and could be identified
correctly in most cases. However, neither B. pseudomal-
lei nor B. mallei were among the clinical isolates tested.
Sporadic cases of melioidosis in cystic fibrosis patients
have been described in the literature and seem to be an
emerging problem [18-22]. Due to increased travel activ-
ity, international trade, climate change, and the potential
threat of bioterrorist attacks infections caused by B.
pseudomallei and B. mallei can become a serious
problem.
The aim of this study was to evaluate the potential
benefit of MALDI-TOF MS for the rapid and reliable
identification and differentiation of B. pseudomallei and
B. mallei.
Results
Construction of a reference database
A custom made set of 34 reference spectra, which are
called main spectra (MSP) in the MALDI Biotyper ter-
minology (Bruker Daltonik GmbH, Bremen, Germany),
was generated and used as the basis for all further calcu-
lations. This reference spectra set included all strains
listed in Table 1 (B. mallei and B. pseudomallei) and
additionally samples from B. ambifaria (DSM 16087), B.
cenocepacia (ATCC BAA-245), B. dolosa (DSM 16088),
B. glathei (ATCC 29195), B. multivorans (DSM 13243),
Table 1 Burkholderia (B.) mallei and B. pseudomallei strains
Bacteria Origin Country Year fliC fliP Motility
B. mallei
ATCC 23344T Human China 1942 + + -
NCTC 120 unknown United Kingdom 1920 + + -
NCTC 10230 Horse Hungary 1961 + + -
NCTC 10247* Human Turkey 1960 + + -
NCTC 10260 Human Turkey 1949 + + -
M1* unknown unknown unknown + + -
M2 unknown unknown unknown + + -
Rotz7 (SVP) unknown unknown unknown + + -
32 unknown unknown unknown + + -
34 unknown unknown unknown + + -
235 unknown unknown unknown + + -
237 unknown unknown unknown + + -
242 unknown unknown unknown + + -
Bogor Horse Indonesia unknown + + -
Mukteswar Horse India unknown + + -
Zagreb Horse former-Yugoslavia unknown + + -
Dubai 7 Horse United Arab Emirates 2004 + + -
B. pseudomallei
ATCC 23343T Human unknown <1957 + - +
EF 15660* unknown unknown unknown + - +
NCTC 1688* Rat Malaysia 1923 + - +
PITT 225A* Human Thailand 1986 + - +
PITT 521 Human Pakistan 1988 + - +
PITT 5691 unknown unknown unknown + - +
120107RR0019 Human Italy 2007 + - +
H05410-0490 Human Asia unknown + - +
03-04448 Human unknown unknown + - +
03-04450 unknown unknown unknown + - +
T type strain.
*Constituents of the reduced reference set dedicated for the discrimination of B. mallei and B. pseudomallei.
Characteristics of Burkholderia (B.) mallei and B. pseudomallei strains used to establish the database for the identification and differentiation with MALDI-TOF mass
spectrometry. Species identity was confirmed by real-time PCR assays targeting a sequence of the fliC gene that is specific for both species but does not
discriminate B. mallei from B. pseudomallei. The real-time PCR assay targeting fliP is specific for B. mallei. Motility was also assessed as a phenotypic marker
because B. pseudomallei is motile while B. mallei is not.
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700388). This set of 34 samples will be referred to as the
‘custom reference set’. The full set of MALDI Biotyper
reference database entries will be referred to as ‘MALDI
Biotyper reference set’. In a first analysis, spectra of the
custom reference set were queried against a combined
database composed of the custom reference set of 34
Burkholderia samples and the MALDI Biotyper refer-
ence set. For every queried spectrum, MALDI Biotyper
software generates a score-based ranked list of organ-
isms. The organism with the highest score is ranked first
(‘top hit’) and its species is taken as the result of the
query. MSP scores are calculated by an algorithm that
compares the masses of a tested sample with thosepresent in the MSP of the spectra collection by agglom-
eration of scores for every mass and performing a nor-
malisation that will result in a final value between 0
(unrelated) and 1000 (identical). For convenience, the re-
sult is given as logarithmic value smaller than or equal
to 3.0. Masses of the tested spectrum will be scored in a
weighted fashion depending on their location within a
narrower or a wider mass tolerance window centred on
the masses of the MSP. Additionally, the score for every
coinciding mass of the tested spectrum will be weighted
according to the frequency with which the correspond-
ing mass of the MSP has been found in the single spec-
tra that were used for the construction of the MSP.
Thus, scores carry information on the number of
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MSP, the mass aberration that is observed between the
corresponding masses of the tested spectrum and the
MSP and the reproducibility of the respective masses of
the MSP. Cut-off values for reliable species determin-
ation cannot be theoretically calculated and have to be
determined empirically. According to the manufacturer,
experience has shown that scores exceeding 2.0 will
allow reliable genus identification and species identifica-
tion in the majority of cases. Scores calculated for all
spectra of the custom reference set among them are
summarized in Figure 1. In the hit lists of all tested spe-
cimen, the highest-ranking entry represented the same
species as the tested specimen, indicating that, within
the given database, the standard MALDI Biotyper identi-
fication procedure reliably allows the determination of
Burkholderia species including the differentiation be-
tween B. mallei and B. pseudomallei. Even though spe-
cies identification was correct in all cases, the
distribution of scores in Figure 1 gave rise to concern
about the reliability of the discrimination of the three
members of the Pseudomallei group: B. thailandensis
produced relatively high scores with some of the B. mal-
lei and B. pseudomallei samples, and B. pseudomallei
generally produced relatively high scores with B. mallei.
Therefore, a set of B. mallei and B. pseudomallei sam-
ples was additionally cultivated and processed in two dif-
ferent laboratories and queried using the custom
reference set as database in order to challenge the iden-
tification procedure. It is known that cultivation condi-
tions can influence the outcome of ICMS experiments.
In an interlaboratory comparison that was performed in
three laboratories with B. thailandensis we had observed
that cultivation on different growth media (Columbia 5%
Sheep Blood agar (CSB), chocolate agar, and McConkey
agar) and different cultivation periods (24, 48 and 72 h)
had a notable influence on the scores in the identifica-
tion procedure (data not shown). To avoid any variance
caused by differing growth conditions, all B. mallei and
B.pseudomallei were grown on CSB and the cultivation
period of 48 h was strictly observed.
Discrimination of B. mallei and B. pseudomallei
Scores between B. mallei samples listed in Table 1 ran-
ged between 2.56 and 2.94, whereas those between B.
pseudomallei samples ranged between 2.25 and 2.89. For
B. mallei samples, the score range over 2.72 was com-
pletely reserved for correct species assignments and the
top scores of all isolates reached this threshold. Due to
the stronger variation of B. pseudomallei, such a well-
defined threshold for correct species assignments could
not be defined for this species.
As MSP will usually not be constructed for routine
samples, the identification procedure with MALDIBiotyper was repeated with single spectra of the B. mal-
lei and B. pseudomallei samples from Table 1. The
results were very similar to those obtained with MSP.
For B. mallei samples, scores between 2.60 and 2.93
were observed, whereas B. pseudomallei were recognized
with scores in the range from 2.57 to 2.92. The top-
ranking hit of the hit-list correctly indicated the species
of all queried samples. Scores of all top-ranking hits
exceeded 2.8. Construction of a score-based dendrogram
of B. mallei and B. pseudomallei samples (Figure 2) with
MALDI Biotyper software resulted in the expected clus-
tering of the two species. Interestingly, the B. pseudo-
mallei type strain ATCC 23343 separated notably from
other B. pseudomallei representatives. This was at least
in part caused by the appearance of two series of masses
between 5,000 and 5,084 Da and 8,500 and 8,565 Da
which were not detected in any of the other samples
(Figure 3). The observation of multiple mass differences
of 14 Da in these series suggests that they were caused
by multiple methylations being specific for this strain.
The mass series reproducibly appeared in all single spec-
tra used to calculate the MSP of the B. pseudomallei
strain ATCC 23343 and were also observed in independ-
ent replicates of the spectra with a freshly cultivated spe-
cimen. The identity of the modified molecule is
unknown. A dendrogram was constructed from the MSP
of the B. mallei and B. pseudomallei strains listed in
Table 1 and the Burkholderia, Chromobacterium, and
Rhodococcus species from Table 2 which were added
from the MALDI Biotyper database (Figure 4). As
expected, score-based distances between B. mallei and
B. pseudomallei were smaller than between the other
Burkholderia species and B. mallei/B. pseudomallei and
B. thailandensis formed a distinct group which was
separated from the other species of the Burkholderia
genus.
The distance relations of B. mallei and B. pseudomallei
were further analysed after transfer of the mass lists into
statistical programming language R. Based on the mass
alignment, a cluster analysis was performed, a distance
matrix was calculated, and the distances within and be-
tween the B. mallei and B. pseudomallei strains were
calculated. To test the influence of the peak intensities
on the clustering behavior, cluster analysis was per-
formed with the quantitative and qualitative data. For
the latter purpose the quantitative alignment containing
the intensities of every mass peak was transformed into
a qualitative binary table by marking the absence or
presence of a mass with 0 and 1, respectively. From both
tables, distance matrices were calculated and visualized
as Sammon-plots (Figure 5). For qualitative and quanti-
tative data the average normalized distances between B.
mallei strains were smaller than between B. pseudomal-






























































































































































































































































































































































































Figure 1 Summary of the MALDI Biotyper queries with the reference spectrum set. The three panels summarize the score-oriented hit lists
that the thirty-four strains of the custom reference set produced when queried against the reference spectrum set plus all representatives of the
Burkholderia genus present in the MALDI Biotyper reference database. The three panels represent queries of B. mallei (A), B. pseudomallei (B) and
other members of the B. genus (C). Filled circles, squares and open circles indicate scores produced by database entries representing B. mallei, B.
pseudomallei or any of the other species in the reference database. Note that for all samples the highest ranking hit represents a member of the
respective Burkholderia species.
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http://www.biomedcentral.com/1471-2180/12/2290.71 when peak intensities of the spectra were included)
confirming the score-based clustering in Figure 2 that
suggests a higher variation among B. pseudomallei than
among B. mallei strains. As a measure for the separation
of the two species, the weighted ratio between the dis-
tances of B. mallei and B. pseudomallei strains withinthe species and the distances between the species was
calculated. Transition from qualitative to quantitative
data showed slight improvement (0.82 vs. 0.74) in the
species separation indicating that peak intensities are
relevant for the discrimination of the two species and






























Figure 2 Dendrogram obtained for Burkholderia mallei and Burkholderia pseudomallei strains. Spectrum-based distances between
members of the B. mallei species are usually smaller than between representatives of B. pseudomallei.
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the presence of two clusters which were congruent with
the two Burkholderia species whereas cluster analysis
based on the qualitative data failed to do so. On basis of
the qualitative data, which weights every mass equally
for the calculation of the distance, B. pseudomallei
ATCC 23343 was notably separated from all otherspectra, most probably because of the multiple modifica-
tions shown in Figure 3.
As some B. mallei and B. pseudomallei specimen from
the reference spectrum set produced quite high scores
with the respective other species, it was essential to test
the practicability of the custom reference set in a routine

































































































































































Figure 3 Unique modification patterns found for two proteins of B. pseudomallei ATCC23343T. Two regions of representative spectra of
the three strains Burkholderia (B.) mallei Bogor (panel A), B. pseudomallei NCTC 1688 (panel B) and B. pseudomallei ATCC 23343 (panel C) are
shown. Two striking series of multiple peaks with m/z distances of 14 Da were observed in B. pseudomallei ATCC 23343 but in no other of the
tested isolates.
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the ‘test set’) only partially overlapped with the custom
reference set (Table 1) so that not only inter-laboratory
variation was tested but also the ability of the custom
reference set to discriminate newly appearing isolates like
those from a glanders outbreak in the United Arabic Emi-
rates in 2004.Using the complete custom reference set as database a
number of misclassifications of the test set isolates oc-
curred. Considering the distribution of scores (Figure 1)
and the distance relations between B. mallei and B.
pseudomallei (Figure 5), this was not unexpected and
obviously a consequence of the indiscriminate inclusion
of all available B. mallei and B. pseudomallei samples
Table 2 Bacteria investigated for specificity testing
Species Strain
Burkholderia (B.) ambifaria LMG 11351
B. ambifaria DSM 16087 T
B. anthina DSM 16086 T
B. anthina LMG 16670
B. caledonica LMG 19076 T
B. caribensis* DSM 13236 T
B. cenocepacia LMG 12614
B. cenocepathia* ATCC BAA-245
B. cepacia MB_7544_05
B. cepacia DSM 11737
B. cepacia 18875_1 CHB
B. cepacia DSM 9241
B. cepacia DSM 50181
B. cepacia LMG 2161
B. cepacia* DSM 7288 T
B. cepacia ATCC 25416 T
B. dolosa DSM 16088
B. fungorum LMG 20227 T
B. gladioli Wv22575 CHB
B. gladioli DSM 4285 T
B. glathei DSM 50014 T
B. glumae DSM 9512 T
B. multivorans LMG 14293
B. multivorans DSM 13243 T
B. phenazinium DSM 10684 T
B. phymatum LMG 21445 T
B. plantarii DSM 9509 T
B. pyrrocinia DSM 10685 T
B. pyrrocinia LMG 14191 T
B. sacchari LMG 19450 T
B. stabilis LMG 14294 T
B. stabilis DSM 16586 T
B. terricola LMG 20594 T
B. thailandensis DSM 13276 T
B. thailandensis* ATCC 700388
B. tropica DSM 15359 T
B. tuberum LMG 21444 T
B. vietnamiensis LMG 10929 T
B. xenovorans LMG 21463 T
Chromobacterium (C.) subtsugae DSM 17043 T
C. violaceum C49 MVO
C. violaceum DSM 30191T
Rhodococcus (R.) equi DSM 1990
R. equi DSM 20295
R. equi DSM 20307 T
R. equi DSM 43950
R. equi* DSM 44426
Table 2 Bacteria investigated for specificity testing
(Continued)
R. equi DSM 46064
R. equi 559 LAL
T type strain.
List of bacteria to be differentiated from Burkholderia mallei and Burkholderia
pseudomallei using MALDI-TOF mass spectrometry. These bacteria include
closely related bacteria, possible sample contaminants, bacteria with very
similar clinical presentation and other relevant bacteria. MSP reference spectra
were constructed for the species indicated with an asterisk (*); all other
samples indicate isolates of the MALDI Biotyper database.
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http://www.biomedcentral.com/1471-2180/12/229into the custom reference set. Classification could be
substantially improved by selecting combinations of iso-
lates of B. mallei and B. pseudomallei to form a dedi-
cated reference set which is optimized for the
discrimination of the two species. To screen the
complete custom reference set of B. mallei and B. pseu-
domallei for appropriate combinations of isolates, the
outcome of a database query was simulated with all per-
mutations of up to four members of each species. The
smallest reference group yielding error-free results was
composed of two B. mallei (M1, NCTC10247) and three
B. pseudomallei (EF15660, PITT 225A, NCTC01688)
isolates which are highlighted by an asterisk in Table 1.
Not surprisingly, these isolates located close to the cen-
ters of their respective species in the Sammon plot
visualization of the distance matrix (Figure 5).
Finally, multivariate statistics on basis of the four dif-
ferent statistical approaches (Genetic Algorithm, Sup-
port Vector Machine, Supervised Neural Network,
Quick Classifier) available in ClinProTools 3.0 showed
that B. mallei and B. pseudomallei could be well sepa-
rated with cross validation results ranging between
98.95% and 100.00% (data not shown). Principal Compo-
nent Analysis (PCA) carried out with ClinProTools 3.0
(Figure 6) further confirmed the separation of both spe-
cies and also the broader distribution of B. pseudomallei
in comparison with B. mallei.
Identification of taxon-specific biomarker ions
Mass spectra of the reference spectrum set were analysed
for species-specific masses which may be used for species
identification independent of the score values considered
so far. For that purpose the mass lists of the MSP gener-
ated with MALDI Biotyper software were evaluated in de-
tail. An alignment of all masses occurring in the spectra
was constructed as a table in which every column repre-
sented the mass spectrum of a sample and every row the
intensity of a mass occurring in a certain mass range. The
alignment contained a total of 350 masses. One of them,
4,410 Da, was found in the spectra of all 34 samples and
also in every one of the single spectra underlying the
MSPs so that this mass can be considered a reliable indi-











































































Figure 4 Spectrum-based dendrogram representing Burkholderia mallei, Burkholderia pseudomallei, and other relevant bacteria. The
dendrogram was constructed based on the MALDI Biotyper scores. Note that distances between B. mallei and B. pseudomallei isolates are small
compared to the distances of other B. species. B. mallei/B. pseudomallei and B. thailandensis separate as distinct group from the other species of
the B. genus.
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Figure 5 Sammon representation of the spectrum-based distance relations of B. mallei and B. pseudomallei. Diagrams A and B were
calculated from qualitative or quantitative distance matrices derived from the mass alignment of the spectra, respectively. Members of the
dedicated reference spectrum set for the discrimination of B. mallei and B. pseudomallei are underlined. Sammon representations allow visualising
distance matrices in a two-dimensional plot with minimized distortion.
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ambifaria, B. cenocepacia, B. dolosa, B. glathe, B. multi-
vorans, B. stabilis). Seven more masses (3,655 [doubly
charged 7,309], 5,195, 6,551, 7,169, 7,309, 8,628 and
9,713 Da) were present in all B. mallei and B. pseudomal-
lei samples but also in one or more of the other Burkhol-
deria species. Considering the close relation of B.
thailandensis with B. mallei and B. pseudomallei, mass
9,713 Da is of interest, which was specific for all B. mallei,
B. pseudomallei, and B. thailandensis samples, i.e. the
Pseudomallei group. Finally, 6,551 Da was present in all B.
mallei and B. pseudomallei samples but in none of the
other species, making it an effective discriminator between
the B. mallei/pseudomallei group and the other represen-
tatives of the genus Burkholderia. Concerning the distinc-
tion of B. mallei and B. pseudomallei, statistical analysis
with ClinProTools 3.0 software revealed a number of
masses with significant class separation between the two
species based on peak intensity. Most significant separ-
ation could be obtained based on the masses 7,553 and
5,794 which differ significantly in intensity between the
two species.Discussion
In recent years MALDI-TOF MS has been introduced in
microbiological laboratories as a time saving diagnostic
approach supplementing morphological, biochemical,
and molecular techniques for identification of microbes
[23]. In several studies the comparability with conven-
tional identification procedures was assessed with gener-
ally good correlation, but discordances were seen on the
species and even on the genus level [24,25]. This prote-
omic profiling approach was successfully applied in rou-
tine identification of bacterial isolates from blood
culture with the exception of polymicrobial samples and
streptococci [26]. The identification of Burkholderia spp.
and other non-fermenting bacteria using MALDI-TOF
MS was investigated in cystic fibrosis (CF) patients as
Burkholderia spp. (mainly of the cepacia-complex) cause
a relevant number of life-threatening infections in these
patients [27-29]. It was demonstrated that MALDI-TOF
MS is a useful tool for rapid identification in the routine
laboratory. B. pseudomallei can be the cause of melioid-
osis in CF patients and travelers to tropical regions, but
this bacterium and the closely related species B. mallei
Table 3 Bacteria used to test the reliability of ICMS-based
discrimination of Burkholderia mallei and Burkholderia
pseudomallei
Species Strain designation Score















Dubai3-10, 14-17* 2.437 - 2.630









*B. mallei isolates from several horses isolated during the glanders outbreak in
UAE 2004.
List of strains used to evaluate the reliability of ICMS-based discrimination of B.
mallei and B. pseudomallei using a dedicated set of reference strains. Column
‘Score’ designates the score value of the top-ranking hit in the dedicated




Figure 6 Principal component analysis of spectra derived from
B. mallei and B. pseudomallei. Principle Component Analysis of ten
strains of B. mallei and ten strains of B. pseudomallei, respectively.
The unsupervised statistical analysis separates both species based on
the three major principle components. While B. mallei form a
relatively uniform cluster, significant diversity can be observed for B.
pseudomallei. Analysis of the spectra from the specimens in Table 1
yielded very similar results (data not shown).
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[18-22,30,31]. Natural catastrophes like the tsunami in
Indonesia (2004) and occasional flooding in other trop-
ical regions resulted in elevated incidence of melioidosis
and several cases among travelers and tourists [32-36].
B. mallei and B. pseudomallei are biological agents
which further underlines the need for rapid detection
tools. Identification of Burkholderia ssp. and distinction
of B. mallei and B. pseudomallei from other species was
feasible. This was also true for the closely related bacter-
ium B. thailandensis. All strains grew well within
48 hours and could then be readily prepared for
MALDI-TOF MS.
Due to the close relationship of B. mallei and B. pseu-
domallei, it was not surprising that the search for
species-identifying biomarker ions discriminating thesespecies was not successful. Obviously, more complicated
mass signatures are required for this purpose and, as we
could show after separate statistical evaluation of quali-
tative and quantitative data, peak intensities also play a
crucial role for the discrimination of B. mallei and B.
pseudomallei. However, group-specific masses like
9,713 Da, standing for the Pseudomallei complex (B.
mallei/B. pseudomallei/B. thailandensis) or 6,551, exclu-
sively found in B. mallei and B. pseudomallei may be of
use for the discrimination of these three species.
For the identification of B. mallei and B. pseudomallei
samples under routine laboratory conditions, it was ne-
cessary to reduce the reference spectrum set to avoid
misclassifications. Interestingly, the reference spectrum
set optimized for spectrum-based discrimination neither
contained the type strain ATCC 23344T (B. mallei) nor
ATCC 23343T (B. pseudomallei). One reason for the ex-
clusion of ATCC 23343 could be the occurrence of two
peak series with repeating mass increments of 14 Da
most probably representing polymethylated proteins.
This strain has been shown to have unique immuno-
logical features. In an immunization experiment with a
panel of 14 B. pseudomallei strains, ATCC 23343
induced monoclonal antibodies in mice which did not
cross-react with any of the other B. pseudomallei
strains [37]. These peculiarities may indicate that this
type strain has been genetically modified by frequent
subcultivation or misuse of media. To our knowledge,
similar modifications which may have an impact on
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These series were specific for the isolate and also for
two molecules within the observed mass range.
Conclusions
In this study we have demonstrated that isolates of the
closely related species B. mallei and B. pseudomallei can
be identified using MALDI-TOF MS. Dangerous and
cumbersome handling under BSL 3 conditions can be
minimized by inactivation of the isolates with ethanol
and subsequent MALDI-TOF MS analysis that requires
much less time than nucleic acid amplification methods
[38]. The reference spectra exhibited a higher homogen-
eity among B. mallei than among B. pseudomallei. The
type strain of B. pseudomallei ATCC 23343 was isolated
decades ago and separated from the other B. pseudomal-
lei specimens in the dendrograms which is probably due
to polymethylation as indicated by two intensive series
of mass increments of 14 Da. To our knowledge, this is
the first report of such a modification in whole cell
MALDI-TOF MS spectra of microorganisms. As
expected for closely related species, especially when one
of them, B. pseudomallei, displays the broad distribution
of MALDI-phenotypes that was observed, the identifica-
tion process requires the selection of spectra from repre-
sentatives of the centers of their respective distance
distributions. Uncritical inclusion of all available samples
as references in a library was counterproductive for the
identification process. Only by selecting an appropriate
set of reference spectra (Table 3) it was possible to iden-
tify all strains. This underlines the need for careful cur-




A comprehensive collection of B. mallei and B. pseudo-
mallei strains, referred to as the ‘reference set’, were tested
(Table 1) and compared with spectra of closely related and
other clinically relevant bacteria (Table 2) included in the
MALDI Biotyper Reference Library (version 3.0, Bruker
Daltonics, Bremen, Germany). Strain identity was con-
firmed using Gram staining, motility testing, and real-time
PCR assays targeting fliC and fliP as described previously
[11,12], and a species-specific DNA-microarray [39].
Strains were obtained from the Friedrich-Loeffler-Institut,
Jena, Germany and the Bundeswehr Institute of Micro-
biology in Munich, Germany. Strain Dubai 7 was kindly
provided by the Central Veterinary Reference Laboratory,
Dubai, UAE. Some strains originated from the Robert
Koch Institute in Berlin, Germany, that coordinated a pro-
ject of the European Union for the “Establishment of
Quality Assurances for Detection of Highly Pathogenic
Bacteria of Potential Bioterrorism Risk”. Spectra from theset of strains enlisted in Table 3, referred to as ‘test set’,
were recorded with an Autoflex mass spectrometer (Bru-
ker) in a second laboratory and queried against the refer-
ence set to test for robustness and inter-laboratory
variation.
Intact cell mass spectrometry (ICMS)
Samples were prepared as described previously [16,40].
Briefly, the bacteria were cultivated under BSL 3 condi-
tions on a nutrient blood agar containing 3% glycerol at
37°C for 48 hours. Specimens from single colonies were
thoroughly suspended in 300 μl water and precipitated
by addition of 900 μL ethanol (98% v/v). This treatment
inactivated the bacteria as was demonstrated by growth
controls and the specimens could be further tested
under BSL 1 conditions. After sedimentation for five
minutes at 10,000 g min-1 the supernatant was carefully
removed and the sediment suspended in 50 μL of 70%
(v/v) formic acid. After mixing with 50 μL acetonitrile,
the suspension was centrifuged as described above and
the supernatant transferred to a fresh tube. 1.5 μL of the
extract was spotted onto a steel MALDI target plate and
allowed to dry at ambient temperature. Finally, the dried
extract was overlaid with 2 μL of a saturated solution of
α-Cyano-4-hydroxycinnamic acid in 50% acetonitrile/
2.5% trifluoroacetic acid as matrix and was again allowed
to dry. A custom-made database of reference spectra
was generated using the MALDI Biotyper software (ver-
sion 2.0, Bruker Daltonik GmbH, Bremen, Germany) fol-
lowing the guidelines of the manufacturer. Each sample
was spotted onto six target spots of a steel MALDI tar-
get plate. Spectra were acquired with an UltraflexTM I
instrument (Bruker Daltonik GmbH) in the linear posi-
tive mode in the range of 2,000 to 20,000 Da. Acceler-
ation Voltage was 25 kV and the instrument was
calibrated in the range between 3,637.8 and 16,952.3 Da
with Bacterial Test Standard calibrant (BTS, Bruker Dal-
tonik GmbH). Four single mass spectra with 500 shots
each were acquired from each spot and a reference
spectrum calculated from the 24 single spectra. Refer-
ence spectra contained the parameters peak mass and
intensity and additional information on the reproducibil-
ity of the mass peaks, i.e. the frequency of occurrence of
every peak in the underlying 24 single spectra. Reference
spectra were generated within the mass range of 2,000
to 20,000 Da with the default parameter settings in the
MALDI Biotyper software. The number of peaks was
limited to 100 per reference spectrum and all peaks of a
reference spectrum were normalized to the most intense
peak with an intensity of 1.0. The minimum frequency
of occurrence within the 24 single spectra was set to
50% for every mass. Peaklists of reference spectra were
exported for further evaluation in the statistical pro-
gramming language R.
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ness of the classification by using MALDI Biotyper soft-
ware, a set of B. mallei and B. pseudomallei test samples
from a second laboratory (Table 3) was queried against
the reference spectra set described above. These spectra
were recorded at the Bundeswehr Institute of Microbiol-
ogy with an Autoflex mass spectrometer (Bruker Dalto-
nik GmbH, Bremens). Spectra were generated for the
test set in the same way as for the reference set. A query
of all test samples was performed and the resulting
scores were transferred into a data matrix, the ‘score
matrix’, in which every column represented a member of
the reference set and every line a test sample. The power
of certain combinations of representatives of the two
classes within the reference set to discriminate samples
of the test set was tested as follows: the columns repre-
senting the combination of reference spectra to be eval-
uated were selected from the score matrix and every
member of the test set was classified by assigning it to
the class of the member of the reduced reference set
with the highest score. The number of correct and in-
correct assignments was then calculated for the test set.
This procedure simulates a MALDI Biotyper query with
a reduced number of spectra in the reference database.
Transfer of data into statistical programming language R
Peak lists of the reference spectra generated by the
MALDI Biotyper software were converted into a format
compatible with the R-package caMassClass which offers
a number of functions to evaluate mass spectra [41] for
further statistical analysis in R version 2.10.1. available at
the R-project homepage [42]. Peak lists were aligned by
the msc.peaks.align command of caMassClass and trans-
formed into a binary mass table where rows represented
all unique masses of the aligned spectra set and every
column represented the spectrum of one sample. The
size of the mass ranges defining a unique peak in the
alignment, designated as bin size, was restricted to a
maximum of 2,000 ppm. Among other features, the al-
gorithm of the msc.peaks.align command minimizes the
bin size in the given range, maximizes the space between
bins and ensures that no two peaks of the same
spectrum are in the same bin. For the calculation of
qualitative data, the presence of the respective mass in
the spectrum of a sample was marked with 1, absence
with 0, i.e. all mass intensities were removed. These
tables were the basis for the calculation of distances
(R-routine ‘dist’, parameter ‘binary’ for the distance
measure) which were used for the construction of clado-
grams, Sammon plots [43], and k-means cluster analysis
using the R-routines ‘hclust’ (parameter ‘ward’ for the
agglomeration method) [44], ‘sammon’ (used with default
settings) and ‘kmeans’ (three initial cluster centers, max-
imum of 100 iterations, Hartigan-Wong algorithm [45]).Statistical analysis with ClinProTools software
Raw spectra from the specimens in Table 3 were
imported into ClinProTools 3.0 software for statistical
analysis. Each species was represented by 20 to 24
spectra to cover measurement variability. The multiple
spectra of multiple species were imported as a “class”
for the respective species. ClinProTools preformed a
normalization and recalibration of mass spectra before
further analysis, thereby reducing measurement variabil-
ity effects significantly. Peak picking was performed
based on the overall average spectrum over the whole
mass range (signal to noise threshold of 5). Further spec-
tra processing parameters were: baseline correction
(convex hull), resolution (300 ppm), smoothing (Savitzky
Golay, 5 cycles with 2 m/z width),
Multivariate statistical analyses were performed using
the four supervised algorithms and PCA which are
implemented in ClinProTools. For the Genetic Algo-
rithm, models with maximum 5 peaks and 50 genera-
tions were calculated and k-nearest neighbor (kNN)
classification was performed with 5 neighbors. Also for
Support Vector Machine the maximum number of peaks
was set to 5 and kNN classification was performed with
5 neighbors. Supervised Neural Network was calculated
with automated optimization of peak number, maximum
25. For the Quick Classifier, a maximum number of dif-
ferentiating peaks of 25 was allowed; selection of peaks
was based on ranking in t-test. For PCA, “level” scaling
was selected.
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